Abstract
New vaccines in infants are generally well tolerated and serious adverse events are rare. We present a patient who developed severe sensorimotor polyneuropathy 2 weeks after the first immunization with hexavalent routine vaccine (INFANRIX hexa). Through intense physiotherapy the infant made a complete recovery.
Acknowledgements
The authors would like to thank Dr Marek Michalski, Dr Elzbieta Rapior, and Dr Danuta Mermer-Kutek from J. Gromkowski Hospital, Wroclaw, Poland, for their clinical expertise and guidance in the treatment of the patient.
Declaration of interest: The authors declare that they have no conflicts of interest. None of the authors has any commercial or other association that might pose a conflict of interest.